Stella Pharma (TSE:4888) Total Stockholders Equity : 円3,079.6 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Total Stockholders Equity?

Stella Pharma's Total Stockholders Equity for the quarter that ended in Sep. 2024 was 円3,079.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Stella Pharma's Book Value per Share for the quarter that ended in Sep. 2024 was 円90.49. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Stella Pharma's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.28.

Stella Pharma Total Stockholders Equity Historical Data

The historical data trend for Stella Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Total Stockholders Equity Chart

Stella Pharma Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

690.03

230.72

3,079.62

2,752.50

2,377.01

Stella Pharma Quarterly Data
	Mar19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial												2,846.33	2,834.91	2,671.20	2,377.01	3,079.58

Stella Pharma (TSE:4888) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Stella Pharma's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3079.577	-	0)	/	34.034
	=	90.49

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Stella Pharma's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(160.008	+	693.288)	/	3079.577
	=	0.28

Stella Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Stella Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043

Website

https://stella-pharma.co.jp

Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines